Loteprednol Etabonate Suspension/ Drops
Product Images NDC 82260-361

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 82260-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Do Not Use (Image 01)

Do Not Use (Image 01)
A warning statement instructing not to use the product if the neckband imprinted with "Protective Seal" and a yellow mortar and pestle symbol is not intact.*
FDA Label Image

Alrex Chemical Formula (Image 02)

Alrex Chemical Formula (Image 02)
Chemical structure of loteprednol etabonate, showing its molecular formula C24H31ClO7 and a molecular weight of 466.96.*
FDA Label Image

5ml Carton (Image 03)

5ml Carton (Image 03)
The packaging label displays Loteprednol Etabonate Ophthalmic Suspension 0.2%, a sterile eye drop suspension in a 5 mL bottle. The label includes active ingredient concentration, storage instructions, and lot-specific safety seals. It is manufactured by Bausch & Lomb Americas Inc., and includes standard prescription drug markings and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.